Compare CVLG & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVLG | ARDX |
|---|---|---|
| Founded | 1986 | 2007 |
| Country | United States | United States |
| Employees | N/A | 489 |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.7M | 797.8M |
| IPO Year | 1996 | 2014 |
| Metric | CVLG | ARDX |
|---|---|---|
| Price | $30.71 | $3.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $49.50 | $12.90 |
| AVG Volume (30 Days) | 136.3K | ★ 4.2M |
| Earning Date | 10-29-2026 | 10-29-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $705,007,000.00 | $2,607,000.00 |
| Revenue This Year | $13.08 | $19.98 |
| Revenue Next Year | $9.15 | $27.70 |
| P/E Ratio | $62.88 | ★ N/A |
| Revenue Growth | ★ 5.12 | N/A |
| 52 Week Low | $18.00 | $3.06 |
| 52 Week High | $49.88 | $8.40 |
| Indicator | CVLG | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 30.56 | 31.84 |
| Support Level | $23.98 | N/A |
| Resistance Level | $36.08 | $3.63 |
| Average True Range (ATR) | 0.93 | 0.12 |
| MACD | -0.15 | 0.01 |
| Stochastic Oscillator | 6.74 | 13.75 |
Covenant Logistics Group Inc together with its wholly-owned subsidiaries, offers truckload transportation and freight brokerage services to customers throughout the continental United States. The company's reportable segments include Expedited, Dedicated Services, Managed Freight, and Warehousing. The expedited segment provides truckload services to customers with high service freight and delivery standards. Dedicated segment provides customers with committed truckload capacity over contracted periods with the goal of three to five years in length. The Managed Freight segment includes brokerage services and TMS. The warehousing segment provides day-to-day warehouse management services to customers who have chosen to outsource this function.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.